Cargando…

EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway

BACKGROUND: The prognosis of pancreatic cancer patients remains relatively poor. Although some patients would receive surgical resection, distant metastasis frequently occurs within one year. Epithelial-mesenchymal transition (EMT), as a pathological mechanism in cancer progression, contributed to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuanyang, Qin, Cheng, Zhao, Bangbo, Li, Zeru, Li, Tianyu, Yang, Xiaoying, Zhao, Yutong, Wang, Weibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021983/ https://www.ncbi.nlm.nih.gov/pubmed/36932397 http://dx.doi.org/10.1186/s12967-023-04043-4

Ejemplares similares

CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway
por: Qin, Cheng, et al.
Publicado: (2022)

Pancreatic cancer stemness: dynamic status in malignant progression
por: Zhao, Yutong, et al.
Publicado: (2023)

STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation
por: Qin, Cheng, et al.
Publicado: (2023)

DHX38 restricts chemoresistance by regulating the alternative pre-mRNA splicing of RELL2 in pancreatic ductal adenocarcinoma
por: Li, Zeru, et al.
Publicado: (2023)

Long Noncoding RNA and Circular RNA: Two Rising Stars in Regulating Epithelial-Mesenchymal Transition of Pancreatic Cancer
por: Yang, Xiaoying, et al.
Publicado: (2022)

Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs
por: Zhao, Bangbo, et al.
Publicado: (2022)

Chromatin Dynamics in Digestive System Cancer: Commander and Regulator
por: Li, Zeru, et al.
Publicado: (2022)

MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1
por: Zhang, Xianglian, et al.
Publicado: (2022)

FBXL10 promotes EMT and metastasis of breast cancer cells via regulating the acetylation and transcriptional activity of SNAI1
por: Yang, Yangyang, et al.
Publicado: (2021)

Author Correction: FBXL10 promotes EMT and metastasis of breast cancer cells via regulating the acetylation and transcriptional activity of SNAI1
por: Yang, Yangyang, et al.
Publicado: (2022)

SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma
por: Hsiao, Yi-Jing, et al.
Publicado: (2016)

REC8 inhibits EMT by downregulating EGR1 in gastric cancer cells
por: Zhao, Junhong, et al.
Publicado: (2018)

DDR2 Coordinates EMT and Metabolic Reprogramming as a Shared Effector of FOXQ1 and SNAI1
por: Mitchell, Allison V., et al.
Publicado: (2022)

Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway
por: Ren, Liangliang, et al.
Publicado: (2022)

Duodenal descending part-jejunum intussusception and upper gastrointestinal bleeding caused by duodenal fibrolipoma: a case report
por: Zhao, Bangbo, et al.
Publicado: (2019)

Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC
por: Wang, Wenjuan, et al.
Publicado: (2019)

SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2
por: Sundararajan, Vignesh, et al.
Publicado: (2020)

The EMT transcription factor Snai1 maintains myocardial wall integrity by repressing intermediate filament gene expression
por: Gentile, Alessandra, et al.
Publicado: (2021)

FOXD1 promotes EMT and cell stemness of oral squamous cell carcinoma by transcriptional activation of SNAI2
por: Chen, Yang, et al.
Publicado: (2021)

The Transcription Factor GLI1 Mediates TGFβ1 Driven EMT in Hepatocellular Carcinoma via a SNAI1-Dependent Mechanism
por: Zheng, Xin, et al.
Publicado: (2012)

A novel prognostic marker and immunogenic membrane antigen: prohibitin (PHB) in pancreatic cancer
por: Wang, Weibin, et al.
Publicado: (2018)

Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas
por: Zhao, Bangbo, et al.
Publicado: (2021)

Review of the possible association between thyroid and breast carcinoma
por: Dong, Liangbo, et al.
Publicado: (2018)

Role of Egr1 on Pancreatic Endoderm Differentiation
por: Tsugata, Takako, et al.
Publicado: (2018)

Anti-tumor effect of HOTAIR–miR-613-SNAI2 axis through suppressing EMT and drug resistance in laryngeal squamous cell carcinoma
por: Zhou, Jing-chun, et al.
Publicado: (2018)

Deletion of Snai2 and Snai3 Results in Impaired Physical Development Compounded by Lymphocyte Deficiency
por: Pioli, Peter D., et al.
Publicado: (2013)

High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID-19 patients
por: Qin, Cheng, et al.
Publicado: (2020)

Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10
por: Fan, Lili, et al.
Publicado: (2020)

SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
por: Sundararajan, Vignesh, et al.
Publicado: (2019)

Prognostic values of SNAI family members in breast cancer patients
por: Li, Deheng, et al.
Publicado: (2020)

SNAI1 and SNAI2 Are Asymmetrically Expressed at the 2-Cell Stage and Become Segregated to the TE in the Mouse Blastocyst
por: Bell, Christine E., et al.
Publicado: (2009)

Absence of a Major Role for the Snai1 and Snai3 Genes in Regulating Skeletal Muscle Regeneration in Mice
por: Norton, Christine R., et al.
Publicado: (2013)

Loss of EGR-1 uncouples compensatory responses of pancreatic β cells
por: Leu, Sy-Ying, et al.
Publicado: (2020)

The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion
por: Fenouille, Nina, et al.
Publicado: (2012)

ZYX promotes invasion and metastasis of gastric cancer cells via WNK1/SNAI1axis
por: Jiang, Yi, et al.
Publicado: (2023)

ZNF300, a recently identified human transcription factor, activates the human IL-2Rβ promoter through the overlapping ZNF300/EGR1 binding site
por: Xue, Lu, et al.
Publicado: (2010)

Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively
por: Tang, Chao, et al.
Publicado: (2019)

GABARAP suppresses EMT and breast cancer progression via the AKT/mTOR signaling pathway
por: Liu, Ying, et al.
Publicado: (2021)

Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach
por: Wang, Na, et al.
Publicado: (2021)

CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma
por: Gu, Jichun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5hcj5daimle5c1degotlro4hdi